Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

654 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis.
Furst DE. Furst DE. Clin Ther. 2004 Dec;26(12):1960-75. doi: 10.1016/j.clinthera.2004.12.019. Clin Ther. 2004. PMID: 15823761 Review.
Minimal disease activity for rheumatoid arthritis: a preliminary definition.
Wells GA, Boers M, Shea B, Brooks PM, Simon LS, Strand CV, Aletaha D, Anderson JJ, Bombardier C, Dougados M, Emery P, Felson DT, Fransen J, Furst DE, Hazes JM, Johnson KR, Kirwan JR, Landewé RB, Lassere MN, Michaud K, Suarez-Almazor M, Silman AJ, Smolen JS, Van der Heijde DM, van Riel PL, Wolfe F, Tugwell PS. Wells GA, et al. Among authors: furst de. J Rheumatol. 2005 Oct;32(10):2016-24. J Rheumatol. 2005. PMID: 16206362
Relationship of serum naproxen concentration to efficacy in rheumatoid arthritis.
Day RO, Furst DE, Dromgoole SH, Kamm B, Roe R, Paulus HE. Day RO, et al. Among authors: furst de. Clin Pharmacol Ther. 1982 Jun;31(6):733-40. doi: 10.1038/clpt.1982.103. Clin Pharmacol Ther. 1982. PMID: 7075121 Clinical Trial.
Tolmetin kinetics and synovial fluid prostaglandin E levels in rheumatoid arthritis.
Dromgoole SH, Furst DE, Desiraju RK, Nayak RK, Kirschenbaum MA, Paulus HE. Dromgoole SH, et al. Among authors: furst de. Clin Pharmacol Ther. 1982 Sep;32(3):371-7. doi: 10.1038/clpt.1982.174. Clin Pharmacol Ther. 1982. PMID: 7105628
Serum concentration and dose-response relationships for carprofen in rheumatoid arthritis.
Furst DE, Caldwell JR, Klugman MP, Enthoven D, Rittweger K, Scheer R, Sarkissian E, Dromgoole S. Furst DE, et al. Clin Pharmacol Ther. 1988 Aug;44(2):186-94. doi: 10.1038/clpt.1988.135. Clin Pharmacol Ther. 1988. PMID: 3293874 Clinical Trial.
Lack of effect of rheumatoid arthritis on clonixin metabolism.
Furst DE, Paulus HE. Furst DE, et al. Clin Pharmacol Ther. 1975 May;17(5):622-6. doi: 10.1002/cpt1975175622. Clin Pharmacol Ther. 1975. PMID: 1092517 Clinical Trial.
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.
Clements PJ, Furst DE, Wong WK, Mayes M, White B, Wigley F, Weisman MH, Barr W, Moreland LW, Medsger TA Jr, Steen V, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner S, Andrews B, Abeles M, Seibold JR. Clements PJ, et al. Among authors: furst de. Arthritis Rheum. 1999 Jun;42(6):1194-203. doi: 10.1002/1529-0131(199906)42:6<1194::AID-ANR16>3.0.CO;2-7. Arthritis Rheum. 1999. PMID: 10366112 Clinical Trial.
Elevated serum levels of soluble interleukin 2 receptor, interleukin 2 and neopterin in diffuse and limited scleroderma: effects of chlorambucil.
Clements PJ, Peter JB, Agopian MS, Telian NS, Furst DE. Clements PJ, et al. Among authors: furst de. J Rheumatol. 1990 Jul;17(7):908-10. J Rheumatol. 1990. PMID: 2213757
Recapitulation of the round-table discussion--assessing the role of anti-tumour necrosis factor therapy in the treatment of rheumatoid arthritis.
Furst DE, Keystone E, Maini RN, Smolen JS. Furst DE, et al. Rheumatology (Oxford). 1999 Nov;38 Suppl 2:50-3. Rheumatology (Oxford). 1999. PMID: 10646494
Clinical pharmacology of combination disease-controlling (DCART/DMARD) therapy in rheumatoid arthritis.
Furst DE. Furst DE. Z Rheumatol. 1998 Feb;57(1):20-4. doi: 10.1007/s003930050053. Z Rheumatol. 1998. PMID: 9566102 Review. No abstract available.
654 results
Jump to page